NNNN
NASDAQ · Biotechnology
Anbio Biotechnology Ltd
$5.58
-0.10 (-1.76%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
—
1Y
-85.23%
YTD
-81.07%
Open$5.69
Previous Close$5.68
Day High$5.72
Day Low$5.46
52W High$51.33
52W Low$5.25
Volume—
Avg Volume264.4K
Market Cap780.09M
P/E Ratio76.47
EPS$0.23
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$29.64
Below
SMA 200
$30.05
Below
RSI (14)
49.5
Neutral
Trend
Death Cross
Bearish
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 29.42M | 41.08M | 1.84B |
| Net Income | 21.78M | 27.38M | -354,337,532 |
| Profit Margin | 74.1% | 70.4% | -19.2% |
| EBITDA | 19.63M | 26.04M | -454,323,212 |
| Free Cash Flow | — | — | -249,462,362 |
| Rev Growth | -28.4% | -28.4% | +17.6% |
| Debt/Equity | — | — | 0.51 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $265.21 | +0.28% | 74.0 | 466.74B |
| AMGN | Amgen Inc | $410.24 | +4.34% | 23.7 | 207.25B |
| GILD | Gilead Sciences Inc | $152.67 | +1.40% | — | 187.10B |
| VRTX | Vertex Pharmaceuticals Inc | $514.99 | +0.84% | 29.7 | 130.64B |
| REGN | Regeneron Pharmaceuticals | $803.90 | +0.72% | 18.6 | 80.58B |
| ALNY | Alnylam Pharmaceuticals Inc | $251.65 | +3.00% | 40.0 | 32.33B |